BenzingaOctober 23, 2026 at 10:01 AM NY4 Days Ago
Goldman Sachs Maintains Neutral on AbbVie, Raises Price Target to $294
Goldman Sachs analyst Asad Haider maintains AbbVie (NYSE:ABBV) with a Neutral and raises the price target from $258 to $294.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
